| abstract |
The present invention relates to the technical field of medicine, and relates to an NLRP3 inflammasome inhibitor and an application thereof. The present invention particularly relates to a compound represented by general formula (I) or a pharmaceutically acceptable salt, a stereoisomer, or a tautomer thereof. The definitions of different groups are as defined in the description. Research shows that the compound represented by general formula (I) or the pharmaceutically acceptable salt, the stereoisomer, or the tautomer thereof has high biological activity on an NLRP3 inflammasome and has a significant clinical development value for the treatment of NLRP3-related diseases. |